Presentation Information
[P2-126]Modulating the immune cell fate with in vivo reprogramming technologies
*Yasuhiro Yamada1 (1. Graduate School of Medicine, The University of Tokyo (Japan))

Comment
To browse or post comments, you must log in.Log in
To browse or post comments, you must log in.Log in